Number of the records: 1  

palonosetron

  1. Topical termpalonosetron
    See link2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one (UF)
    2-QHBIQO (UF)
    Aloxi (UF)
    Palonosetron Hydrochloride (UF)
    Palonosetron, (3R)- (UF)
    Palonosetron, (R-(R*,R*))-isomer (UF)
    Palonosetron, (R-(R*,S*))-isomer (UF)
    Palonosetron, (S-(R*,S*))-isomer (UF)
    palonosetroni hydrochloridum (UF)
    RS 25233-197 (UF)
    RS 25233-198 (UF)
    RS 25259 (UF)
    RS 25259-197 (UF)
    RS 25259-198 (UF)
    RS-25233-197 (UF)
    RS-25233-198 (UF)
    RS-25259 (UF)
    RS-25259-197 (UF)
    RS-25259-198 (UF)
    See alsochinuklidiny
    isochinoliny
    antiemetika (PA)
    serotoninové receptory 5-HT3 - antagonisté (PA)
    Linking entryPalonosetron
    ConspectD03. - 605. - 687. - 319
    D03. - 633. - 100. - 531. - 629
    NoteIsoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.
    DatabaseMESH
    References (2) - MESH
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.